Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langdon

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2008
Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signalingRakel López de Maturana, Adam J Pawson, Zhi-Liang Lu, et al.
BMC Cancer|November 5, 2011
GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell linesKevin Morgan, Colette Meyer, Nicola Miller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenograftsS P Langdon, A A Ritchie, M Muir, et al.
Journal of Medicinal Chemistry|June 1, 1986
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamideE N Gate, M D Threadgill, M F Stevens, et al.
Oncology Reports|May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factorsJ M Bartlett, G J Rabiasz, W N Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumoursJ M Bartlett, S P Langdon, W N Scott, et al.
Cancer Research|July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agentJ A Hickman, M F Stevens, N W Gibson, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2012
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell linesJean-Yves Winum, Fabrizio Carta, Carol Ward, et al.
Cancer Research|November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell linesS P Langdon, M M Hawkes, F G Hay, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2008
Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signalingRakel López de Maturana, Adam J Pawson, Zhi-Liang Lu, et al.
BMC Cancer|November 5, 2011
GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell linesKevin Morgan, Colette Meyer, Nicola Miller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenograftsS P Langdon, A A Ritchie, M Muir, et al.
Journal of Medicinal Chemistry|June 1, 1986
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamideE N Gate, M D Threadgill, M F Stevens, et al.
Oncology Reports|May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factorsJ M Bartlett, G J Rabiasz, W N Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumoursJ M Bartlett, S P Langdon, W N Scott, et al.
Cancer Research|July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agentJ A Hickman, M F Stevens, N W Gibson, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2012
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell linesJean-Yves Winum, Fabrizio Carta, Carol Ward, et al.
Cancer Research|November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell linesS P Langdon, M M Hawkes, F G Hay, et al.
Pageof 18